USPTO withdraws proposed patent rule criticized by pharma industry
The US Patent and Trademark Office has withdrawn its controversial proposal for a new rule that would make it easier to challenge groups of patents …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
